Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
28.93
-0.82 (-2.76%)
At close: Aug 20, 2026, 4:00 PM EDT
28.93
0.00 (0.00%)
Pre-market: Aug 21, 2026, 4:34 AM EDT
Maze Therapeutics Employees
Maze Therapeutics had 141 employees as of December 31, 2025. The number of employees increased by 16 or 12.80% compared to the previous year.
Employees
141
Change (1Y)
16
Growth (1Y)
12.80%
Revenue / Employee
$141,844
Profits / Employee
-$947,447
Market Cap
1.61B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 141 | 16 | 12.80% |
| Dec 31, 2024 | 125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Ascentage Pharma Group International | 767 |
| Vir Biotechnology | 367 |
| Innoviva | 159 |
| Absci | 140 |
| AnaptysBio | 104 |
| Bicara Therapeutics | 103 |
| Tyra Biosciences | 87 |
MAZE News
- 7 days ago - Maze Therapeutics Announces Appointments to Its Board of Directors - GlobeNewsWire
- 9 days ago - Maze Therapeutics reports Q2 EPS (76c), consensus (70c) - TheFly
- 9 days ago - Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 9 days ago - Maze Therapeutics Earnings release: Q2 2026 - Filings
- 9 days ago - Maze Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Maze Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Maze Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Maze Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts